The relationship between the diet, microelements, macronutrients and vitamins on the schizophrenia – literature analysis
DOI:
https://doi.org/10.12775/JEHS.2020.10.09.043Keywords
schizophrenia, diet, microelements, macronutrients, vitaminsAbstract
Introduction: Schizophrenia is a disease that affects approximately 1% of the population. It begins in adult humans. It turns out that there are factors that predispose to schizophrenia, and by modifying your lifestyle, you can reduce the likelihood of its occurrence. One of such factors is the diet and microelements, macronutrients and vitamins that we consume every day.
The aim of the study: The aim of this study was to find out the relationship between the diet, microelements, macronutrients, vitamins and the schizophrenia disease.
Material and method: The research of articles was done in the websites such as PubMed and Google Scholar.
Description of the state of knowledge: Ketogenic and gluten-free diet are promising tools in decreasing the symptoms of and treating schizophrenia. Micro- and macroelement imbalances are present in schizophrenic patients, but their correlation with development of schizophrenia is not clear. Folate, vitamin D and vitamin B12 supplementation could prove useful in the treatment.
Summary: There are many studies that try to combine the implications of a balanced diet and the proper supply of elements and their impact on schizophrenia's occurence and symptomology. Still, futher investigation of these topics is needed to provide the most suitable guidelines and applications of proper nutrition of schizophrenic patients.
References
Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE, Charlson FJ, Norman RE, Flaxman AD, Johns N, et al. Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet. 2013;382:1575–1586. doi: 10.1016/S0140-6736(13)61611-6.
[1] Janoutová J, Janácková P, Serý O, Zeman T, Ambroz P, Kovalová M, Varechová K, Hosák L, Jirík V, Janout V. Epidemiology and risk factors of schizophrenia. Neuro Endocrinol Lett. 2016;37(1):1-8.
Palijan TŽ, Kovačević D, Vlastelica M, Dadić-Hero E, Sarilar M. Quality of Life of Persons Suffering from Schizophrenia, Psoriasis and Physical Disabilities. Psychiatr Danub. 2017 Mar;29(1):60-65
Hofer A, Mizuno Y, Wartelsteiner F, Wolfgang Fleischhacker W, Frajo-Apor B, Kemmler G, Mimura M, Pardeller S, Sondermann C, Suzuki T, Welte A, Uchida H. Quality of life in schizophrenia and bipolar disorder: The impact of symptomatic remission and resilience. Eur Psychiatry. 2017 Oct;46:42-47
Mueser K.T., McGurk S.R., Schizophrenia. The Lancet, 363 (9426), London, England 2004, s. 2063–2072, DOI: 10.1016/S0140-6736(04)16458-1, PMID: 15207959.
Janssen I. et al. Childhood abuse as a risk factor for psychotic experiences, „Acta Psychiatrica Scandinavica”, 109 (1), 2004, s. 38–45, PMID: 14674957.
Suvisaari J, Keinänen J, Eskelinen S, Mantere O. Diabetes and Schizophrenia. Curr Diab Rep. 2016 Feb;16(2):16
Phensy A, Driskill C, Lindquist K, Guo L, Jeevakumar V, Fowler B, et al. Antioxidant Treatment in Male Mice Prevents Mitochondrial and Synaptic Changes in an NMDA Receptor Dysfunction Model of Schizophrenia. eneuro. 2017;4. doi:10.1523/eneuro.0081-17.2017.
Mccreadie, R. G., Kelly, C., Connolly, M., Williams, S., Baxter, G., Lean, M., & Paterson, J. R. (2005). Dietary improvement in people with schizophrenia. British Journal of Psychiatry, 187(4), 346-351. doi:10.1192/bjp.187.4.346
Joukamaa, M., Heliovaara, M., Knekt, P. et al (2001) Mental disorders and cause specific mortality. British Journal of Psychiatry, 179, 498–502
McCreadie, R. G., MacDonald, E., Blacklock, C. et al (1998) Dietary intake of schizophrenia patients in Nithsdale, Scotland: Case Control Study. BMJ; 317, 784–785
McCreadie, R. G. (2003) Diet, smoking and cardiovascular risk in people with schizophrenia. Descriptive study. British Journal of Psychiatry, 183, 534–539
Zimmerman, U., Kraus, T., Himmerich, H. et al (2003) Epidemiology, implications and mechanisms underlying drug-induced weight gain in psychiatric patients. Journal of Psychiatric Research, 37, 193–220
Fontaine, K. R., Moonseong, H., Harrigan, E. P. et al (2001) Estimating the consequences of antipsychotic induced weight gain on health and mortality rate. Psychiatric Research, 101, 277–288
Włodarczyk, A., Wiglusz, M. S., & Cubała, W. J. (2018). Ketogenic diet for schizophrenia: Nutritional approach to antipsychotic treatment [Abstract]. Medical Hypotheses, 118, 74-77. doi:10.1016/j.mehy.2018.06.022
Gilbert-Jaramillo, J., Vargas-Pico, D., Espinosa-Mendoza, T., Falk, S., Llanos-Fernandez, K., Guerrero-Haro, J., . . . Palmer, C. (2018). The effects of the ketogenic diet on psychiatric symptomatology, weight and metabolic dysfunction in schizophrenia patients. Clinical Nutrition and Metabolism, 1(1). doi:10.15761/cnm.1000105
Ketogenic diet for schizophrenia: Clinical implication. (n.d.). Retrieved September 13, 2020, from https://www.ncbi.nlm.nih.gov/pubmed/31192814
Levinta, A., Mukovozov, I., & Tsoutsoulas, C. (2018). Use of a Gluten-Free Diet in Schizophrenia: A Systematic Review. Advances in Nutrition, 9(6), 824-832. doi:10.1093/advances/nmy056
Singh M, Kay SR. Wheat gluten as a pathogenic factor in schizophrenia. Science 1976;191(4225):401–2
Reichelt KL, Sagedal E, Landmark J, Sangvik BT, Eggen O, Scott H. The effect of gluten-free diet on urinary peptide excretion and clinical state in schizophrenia. J Orthomol Med 1990;5(4):223–39.
Jackson J, Eaton W, Cascella N, Fasano A, Warfel D, Feldman S, Richardson C, Vyas G, Linthicum J, Santora D et al. A gluten-free diet in people with schizophrenia and anti-tissue transglutaminase or anti-gliadin antibodies. Schizophr Res 2012;140(1–3):262–3
McCreadie, R., Kelly, C., Connolly, M., Williams, S., Baxter, G., Lean, M., & Paterson, J. (2018, January 02). Dietary improvement in people with schizophrenia: The British Journal of Psychiatry. Retrieved September 13, 2020, from https://doi.org/10.1192/bjp.187.4.346
Lin T, Liu T, Lin Y, Yan L, Chen Z, Wang J. Comparative study on serum levels of macro and trace elements in schizophrenia based on supervised learning methods. J Trace Elem Med Biol. 2017;43:202-208. doi:10.1016/j.jtemb.2017.03.010
Ma J, Yan L, Guo T, et al. Association between Serum Essential Metal Elements and the Risk of Schizophrenia in China. Sci Rep. 2020;10(1):10875. Published 2020 Jul 3. doi:10.1038/s41598-020-66496-7
Liu T, Lu QB, Yan L, et al. Comparative Study on Serum Levels of 10 Trace Elements in Schizophrenia. PLoS One. 2015;10(7):e0133622. Published 2015 Jul 17. doi:10.1371/journal.pone.0133622
Joe P, Petrilli M, Malaspina D, Weissman J. Zinc in schizophrenia: A meta-analysis. Gen Hosp Psychiatry. 2018;53:19-24. doi:10.1016/j.genhosppsych.2018.04.004
Cao B, Yan L, Ma J, et al. Comparison of serum essential trace metals between patients with schizophrenia and healthy controls. J Trace Elem Med Biol. 2019;51:79-85. doi:10.1016/j.jtemb.2018.10.009
Li Z, Liu Y, Li X, et al. Association of Elements with Schizophrenia and Intervention of Selenium Supplements. Biol Trace Elem Res. 2018;183(1):16-21. doi:10.1007/s12011-017-1105-0
Goff DC, Bottiglieri T, Arning E, et al. Folate, homocysteine, and negative symptoms in schizophrenia. Am J Psychiatry. 2004;161(9):1705-1708. doi:10.1176/appi.ajp.161.9.1705
Herrán A, García-Unzueta MT, Amado JA, López-Cordovilla JJ, Díez-Manrique JF, Vázquez-Barquero JL. Folate levels in psychiatric outpatients. Psychiatry Clin Neurosci. 1999;53(4):531-533. doi:10.1046/j.1440-1819.1999.00572.x
McGrath JJ, Eyles DW, Pedersen CB, et al. Neonatal Vitamin D Status and Risk of Schizophrenia: A Population-Based Case-Control Study. Arch Gen Psychiatry. 2010;67(9):889–894. doi:10.1001/archgenpsychiatry.2010.110
Itzhaky D, Amital D, Gorden K, Bogomolni A, Arnson Y, Amital H. Low serum vitamin D concentrations in patients with schizophrenia. Isr Med Assoc J. 2012;14(2):88-92.
Zhang Y, Hodgson NW, Trivedi MS, et al. Decreased Brain Levels of Vitamin B12 in Aging, Autism and Schizophrenia. PLoS One. 2016;11(1):e0146797. Published 2016 Jan 22. doi:10.1371/journal.pone.0146797
Kemperman RF, Veurink M, van der Wal T, et al. Low essential fatty acid and B-vitamin status in a subgroup of patients with schizophrenia and its response to dietary supplementation. Prostaglandins Leukot Essent Fatty Acids. 2006;74(2):75-85. doi:10.1016/j.plefa.2005.11.004
Downloads
Published
How to Cite
Issue
Section
License
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 780
Number of citations: 0
